Monday, 10 August 2015

A Guide On Prostate Cancer Screening

By Olive Pate


Great progress has been made in cancer treatment. Prostate cancer screening is a process that involves the detection of cancerous growth before its symptoms become visible despite the slow growth of the cancerous cells which may grow or not.

Tests are often carried out to view and tell the extent and presence of the prostate cancer. The first test to determine any abnormalities around the prostate glands and the presence of any lumps on the glands. This is referred to as the Digital-Rectal Exam carried out by a physician who introduces a lubricated finger with gloves to the rectum.

The degree of the prostate specific antigens which are also produced by the prostate in the blood are measured by the Prostate Specific Antigen test. This test examines the PSA levels and measures its relation to the cancer. They are higher in men with the tumor present in their glands. The PSA levels risk increasing due to certain issues such as medical processes and medications and in other situations age and race could affect them too.

The asymptomatic cancer could be examined and probed by the The PSA based screening technique. There are various types of asymptomatic cancer that are aggregated by the screen tests, this may cause either a non progressive or progressive cancerous growth that would have remained asymptomatic in other instances.

The main purpose of the screening is to reduce the deaths of the patients as well as the metastasization of the disease. Prostate tumor patients have three possible occurrences. Some of them may die despite the early detection and adequate treatment, some of them will survive even with no prior screening procedures and some of them survive with the early detection and proper adequate treatment however, there's a lesser chance of survival in this case.

However the screening procedure may harm the patient in some cases. The PSA test mostly produces a fifty-fifty results that are not certain it may be true or false. These results are mostly brought up due to negative psychological situations such as constant worrying about cancer. Men who undergo biopsy may experience pain, fever, infections, urinary difficulties and bleeding and are required to consult medical help and require constant follow up. The long-term effect of the PSA screening is yet to be fully discovered. Although certain studies carried out have shown that the cancer's mortality reduction rates after the screens are very small.

The screen detection and the treatment process of the tumor have caused most if not all effects experienced by most patients, they are too persistent and unprecedented thus may cause an early death.

Men are constantly exposed to effects that are more than the benefits brought about by the screen tests and treatment procedures. Over treatment as a result of the screen tests and treatment processes cause the men to experience unexpectedly harmful effects that would interfere with the asymptomatic stage of the disease.

Balance between the benefits and detriments of early diagnosis and treatment is necessary in determining if there's a chance of survival for the patient or proves to be detrimental to the prostate tumor due to the constant harm caused by the medical procedures.




About the Author:



No comments:

Post a Comment